Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Sell
82,200
-100
-0.1% -$22.2K 0.04% 377
2025
Q4
$18.8M Buy
82,300
+14,000
+20% +$3.19M 0.06% 248
2025
Q3
$15.8M Buy
68,300
+30,800
+82% +$6.27M 0.06% 245
2025
Q2
$6.96M Buy
37,500
+19,300
+106% +$3.59M 0.03% 410
2025
Q1
$3.81M Buy
+18,200
New +$3.54M 0.02% 541
2024
Q4
Sell
-3,300
Closed -$651K 2348
2024
Q3
$651K Buy
+3,300
New +$616K ﹤0.01% 1454
2024
Q1
Sell
-16,500
Closed -$2.56M 2203
2023
Q4
$2.56M Sell
16,500
-1,900
-10% -$277K 0.02% 541
2023
Q3
$2.74M Buy
+18,400
New +$2.7M 0.03% 494
2022
Q4
Sell
-5,000
Closed -$671K 2405
2022
Q3
$671K Buy
5,000
+1,900
+61% +$273K 0.01% 1262
2022
Q2
$474K Buy
+3,100
New +$474K 0.01% 1690
2022
Q1
Sell
-81,300
Closed -$11M 2998
2021
Q4
$11M Buy
81,300
+78,000
+2,364% +$9.21M 0.06% 148
2021
Q3
$355K Sell
3,300
-49,400
-94% -$5.64M ﹤0.01% 2289
2021
Q2
$5.94M Buy
52,700
+46,200
+711% +$5.2M 0.05% 269
2021
Q1
$703K Sell
6,500
-26,900
-81% -$2.88M 0.01% 1519
2020
Q4
$3.58M Buy
33,400
+22,500
+206% +$2.16M 0.07% 200
2020
Q3
$954K Buy
+10,900
New +$1.03M 0.03% 581

Other funds holding ABBV

HRT Financial's ABBV Position: Q1 2026 in Review

HRT Financial opened a new position in AbbVie (ABBV) in Q1 2026: 926,410 shares worth $201M. The stake represents 0.5% of the portfolio and ranks #22 among its holdings. This is a return to the name: HRT Financial previously reported a position in ABBV as recently as Q3 2025.

HRT Financial first reported a position in ABBV in Q4 2014 and has held it in 19 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • HRT Financial held 926,410 shares of AbbVie worth $201M as of Q1 2026.
  • AbbVie was a new HRT Financial position in Q1 2026.
  • AbbVie made up 0.5% of HRT Financial's portfolio in Q1 2026, its #22 holding.
  • HRT Financial first reported a position in AbbVie in Q4 2014 and has held it in 19 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.